Cheng et al. found that glutaminase-silenced glioblastoma cells induce a compensatory anaplerotic mechanism catalysed by pyruvate carboxylase to use glucose-derived pyruvate rather than glutamine for anaplerosis25, thus, demonstrating the high flexibility of cancer cells to circumvent perturbations in their metabolic networks. The gene discussed is GLS; the disease is glioblastoma.